Home > Products > Albumin Removal Kits >

AlbuSorb™ PLUS - Albumin + IgG Depletion Kit From Serum or Plasma



 
Alternative Views:


Functional Proteomics
Price: $395.00


Product Code: APK285


APK285:
  

Qty:
Description Applications Specifications
 

  • >400 µg total serum protein mass (> 85% Albumin, >85% IgG depleted)
    from 25 µl serum prep

  • Affinity-type equivalence, virtually no cross-reactivity with other proteins

  • Disposable, no column regeneration or cross-contamination

  • Combines unique bead technology, not based on Blue-dye affinity, with optimized Protein A

  • Mild conditions maintains structural integrity and simple transfer to secondary analysis

  • Suitable for immunoassay, Western blot, 1 & 2D Electrophoresis, enzyme assay, LC-MS

  • Tested species include human, sheep, bovine, rabbit, mouse, rat


Poly-electrolytes are polymers with repeating units of stationary charges. AlbuSorb™ comes from a class of solid-phase, or surface-based, elastomeric poly-electrolytic surfaces that bind proteins through an empirically derived chemistry combining elements of polymer composition, cross-linking architecture and charge properties. AlbuSorb™ combines with an optimized immobilized Protein A to create AlbuSorbPLUS. Unlike immuno-affinity, the surfaces utilized are disposable eliminating cycle to cycle variance and cross-contamination. AlbuSorbPLUS is supplied as a powder. Simply weigh, centrifuge and/or filter, and recover the albumin depleted serum in the supernatant.

Click here to view AlbuSorb™ PLUS Product Sheet
References

References for AlbuSorbPLUS

Application Report
AlbuSorb™ Product Extension combines Albumin and Immunoglobulin Depletion in a Consumable Format


References For
AlbuSorb

Cerebrospinal Fluid
Gwenael Pottiez, Pawel Ciborowski. Proteomic Profiling of Cerebrospinal Fluid Expression Profiling In Neuroscience Neuromethods.2012;64:245-270

Synovial fluid
Happonen KE, Fürst CM, Saxne T et al. PRELP protein inhibits the formation of the complement membrane attack complex.Journal of Biological Chemistry.2012;287(11):8092-100

Serum
Dr.Swapan Roy; Amenah Soherwardy; Ravish Amin; Matthew Kuruc Biotech Support Group LLC, Monmouth Junction, NJ - Application Report. AlbuSorb™ Product Extension combines Albumin and Immunoglobulin Depletion in a Consumable Format

Holmberg R, Refai E, Höög A.Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proceedings of the National Academy of Sciences.2011;108(26):10685-9.

Tang MX, Ogawa K, Asamoto M. Effects of Nobiletin on PhIP-Induced Prostate and Colon Carcinogenesis in F344 Rats Nutrition and Cancer.2011;63(2):227-33

Holmberg, Rebecka Apolipoprotein CIII and Ljungan virus in diabetes 2010. Doctoral Thesis

Lu Q, Zheng X, McIntosh T Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. Analytical Chemistry.2009;81(21):8715-23

Urine
Zubiri, Irene, et al. "Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis." Journal of proteomics 96 (2014): 92-102.

Patent
Berggren, Per Olaf, Yang, Shao-Nian. 2012. Methods For Treating And/Or Limiting Development Of Diabetes.U.S. Patent 20120328630 Kind Code: A1, filed June 25, 2012, and issued December 27, 2012.